Tag
The article explores how turnkey telehealth services enable virtually anyone—from established companies like JustAnswer to influencers—to sell GLP-1 weight loss drugs online, highlighting the rapid expansion of the digital health market and the role of infrastructure providers.
A journalist recounts being scammed by an online telehealth service that charged him for unwanted GLP-1 medications and refused refunds, highlighting a broader pattern of consumer fraud in the growing online weight-loss drug market.
The article explains the biochemical mechanism of GLP-1 agonists, including the new drug retatrutide, and how they regulate appetite and energy metabolism by mimicking natural hormones.